Fig. 4From: Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cellsCalibration curves of indirect ELISAs. Each antibody’s binding capacity to TK1 was tested in indirect ELISA. A 4-point non-linear regression analysis was performed for each dose–response curve. Antibodies graphs are combined per epitopeBack to article page